Robert L. Dubin, MD. FACP, FACE, DABOM

* Associate Professor Louisiana State University

* Program director: Obesity Medicine Fellowship

* Physician Scientist: Pennington Biomedical Research Center

* Clinical Specialist: Endocrinology, diabetes obesity and metabolism: Louisiana State University Health Sciences

• American Board of Internal Medicine (ABIM), 01/01/2014-present
• ABIM: Endocrinology, Diabetes and Metabolism, 01/01/2014-present
• American Board of Obesity Medicine (ABOM), 01/01/2016-12/31/2026
• American Heart Association, ACLS Certified, 01/29/2023-01/29/2027
• Florida, ME88538, 07/2003-07/2023
• Louisiana, MD.204663, 10/2023-present
• North Carolina, 2026-01741, 04/01/2026-present
• American College of Physicians, fellow (FACP)
• American Association of Clinical Endocrinologists, fellow (FACE)

• American College of Physician, Fellow, 2003-present
• The Obesity Society, 2008-present
• The Endocrine Society, 2008-present
• The American Diabetes Association, 2008-present
• American Osler Society, 2008-present
• American Association of Clinical Endocrinologist (AACE), Fellow, 2011-present
• International Society of Clinical Densitometry (ISCD), 2011-present
• The Louisiana Obesity Society (LOS), board member, 2024-present

• Incretin-based therapies for metabolic diseases
• Body composition and obesity
• Endocrine diseases in the elderly
• Pipeline drugs for metabolic diseases

Carol Volkert-Dubin (married 30 years)

Peer-Reviewed Publications:

1. Dubin R, Hall C, Pileri C, Kudlechek P, Li X, Johnson M, Yee J, Anderson R.J.

Thermostable (SULT1A1) and Thermolabile (SULT1A3) Phenol Sulfotranferases in

Human Osteosarcoma and Osteoblast Cells. Bone. June 2001 (28), 6, 617-624

2. Leavy, J, Dubin R, Singh N, Kaminsky D. Silo-Filler's Disease, the Acute Respiratory

Distress Syndrome, and Oxides of Nitrogen. Annals of Internal Medicine. September

2004 (41), 5, 410-411.

3. Dubin RL, Rasul K, Berthaut LG, et al: Buckle up for safety: seat belt usage in extremely obese patients. J Invest Med 2012; 60 (1) 346

4. Dubin, RL, Kennon AW, Baldwin CB. “Eat Less and Exercise More!” Follow-Up at Six

Weeks versus Six Months. J Invest Med 2012; 60 (1) 432

5. Dubin, RL, Fusiler, K, Greenway F. The Effect of Modified Sham Feeding with Orlistat

in Overweight and Obese Subjects: A Pilot Study. J Invest Med 2013; 61 (2) 397

6. Conrad A, Dubin R, Uwaifo, G. Clinical Pharmacist Services in a Multidisciplinary

Weight Management Clinic. Journal of Health Care for the Poor and Underserved.

24(2013) 29-35

7. Primeaux S, Tzeng T, Allerton, T, Chiang M, Cosentino G, Dubin R, Varughese A, Moore R, Geiselman P, Greenway F, Uwaifo G. Differences in short-term food preferences following vertical sleeve gastrectomy and Rou-en-Y gastric bypass surgery. Obes Res Clin Pract. 2015 (6) 628-32

8. Primeaux, S, Dubin, R, Greenway, F. Orlistat Mouth Rinse: Using the Tongue to Deliver Anti-Obesity Medication. Diabetes, Obesity and Metabolism. 2023 (25) 2236-2242

9. Dubin R, Heymsfield S, Ravussin E, Greenway F. Glucagon-like peptide-1 receptor agonists-based agents and weight loss composition: Filling the Gaps. Diabetes, Obesity and Metabolism. Dec 26, 2024 (12) 5503-5518

10. Dubin, R. Diagnosis of Gestational Diabetes after Roux-en-Y Gastric bypass: A comparative Analysis of Three Methods. Surgery for Obesity and Related Diseases 21 (8), 899-900 May 2025

11. ASHLEY H. TJADEN, KARLA A. TEMPLE, SHARON EDELSTEIN, WILLIAM C. KNOWLER, VALLABH SHAH, SHIHCHEN KUO, PANDORA WANDER, MARIA ROSARIO G. ARANETA, JAMES M. NOBLE, DANA DABELEA, ROBERT L. DUBIN, JILL P. CRANDALL, DPP RESEARCH GROUP; 1447-P: Impact of the COVID-19 Pandemic on the Diabetes Prevention Program Outcomes Study (DPPOS). Diabetes 20 June 2025; 74 (Supplement_1): 1447–P.

12. Dubin RL. Bone Health and Obesity Treatments: It's Time to Give Bone Its Due. Obesity (Silver Spring) 2025. Epub 20251028. doi: 10.1002/oby.70074. PubMed PMID: 41151991.

13. Change in Allostatic Load Across 22 Weeks in African American Women With Obesity: Differences by Food Security Status. CA Myers, RA Beyl, SA Yang, DS Hsia, RL Dubin, TW Ardoin, JW Apolzan

Current Developments in Nutrition (9) Supp 2. May 2025.

14. Food Insecurity in African American Women with Obesity: Baseline Physiological Characteristics

J Apolzan, R Beyl, D Hsia, R Dubin, T Ardoin, C Myers

OBESITY 32, 126-126. 2025

14. Hannah E. Cabre, Courtney M. Peterson, Gareth R. Dutton, Kimberly L. Drews, Stephanie T. Broyles, Robert Dubin, Laura Q. Rogers, Catherine Champagne, Dennis T. Villareal, Daniel S. Hsia, Leanne M. Redman, Corby K. Martin, Strategies and challenges for the recruitment of young healthy participants in the dietary approaches to longevity and health (DiAL health) pilot trial, Contemporary Clinical Trials, Volume 160, 2026,108143,ISSN 1551-7144.

15. Dubin Robert L, Sanders, T, Schwabb, H, Heymsfield S, Greenway F. Glucagon-like peptide-1 receptor agonists-based agents and weight loss composition: Filling more Gaps. June Special Issue Obesity. 2026

Abstracts/Presentations:

1. Detection and Characterization of Phenolsulfotransferases in Human Osteosarcoma Cells.

Presented at the Midwest Student Research Forum. Omaha, NE. February 21, 1998, and

Endo ’98. June 24, 1998. New Orleans, LA.

2. Angiotension-Converting Enzymes Inhibitors Increase Basal Glucose Uptake in Human

Skeletal Muscle. Dubin, R., Bindra S, Wang Z, Zhang H, Cefalu W. Abstract # 2340-PO.

62nd Annual Meeting of the American Diabetes Association. June 2002. San Francisco, CA.

3. Silo-Filler’s Disease treated with Inhaled Nitric Oxide: The Double-Edged Sword of Nox

Species. Dubin R, Leavy J, Singh N, Kaminsky D. Regional Clinical Vignette Winner.

ACP-ASIM. Stowe, VT. October 2002. National Clinical Vignette Winner. ACP-ASIM.

Annual Session. April 2003.San Diego, CA.

4. Clinical Evaluation of a Novel Partial Meal Replacement for Obese Adults. Dubin, R,

James J, Barrie J. Presentation at the Obesity Society Annual Meeting, October 2010. San

Diego, CA. Buckle Up for Patient Safety: Seat Belt Usage in Extremely Obese Patients. Dubin, RL,

5. Rasul K, Berthaudt LG, Cefalu WT, Uwaifo G. Poster Presentation Abstract# 127.American Federation for Medical Research. Southern Regional Meeting. February 9, 2012. New Orleans, LA.

6. 7. “Eat Less and Exercise More!” Follow-Up at Six Weeks versus Six Months. Dubin, RL, Kennon AW, Baldwin CB. Oral Presentation Abstract#441. American Federation for Medical Research. Southern Regional Meeting. February 11, 2012. New Orleans, LA.

7. Ectopic Adipose Distribution in Normal Glucose Tolerant, Impaired Glucose Tolerant and Type 2 Diabetic Vietnamese Americans. Luu L, Dubin, R, Allerton T, Uwaifo G, Cefalu W. Poster Presentation/Abstract 2039-P. 72nd Scientific Sessions. American Diabetes Association (ADA). June 10, 2012. Philadelphia, PA.

8. Vietnamese Americans Demonstrate Markedly Impaired Insulin Secretion Across Glycemic Status. Luu L, Allerton T, Uwaifo G, Dubin, R, Cefalu W. Poster Presentation/Abstract 1750-P. 72nd Scientific Sessions. American Diabetes Association. (ADA) June 11, 2012. Philadelphia, PA.

9. Hypovitaminosis D in Patients Awaiting Weight-Loss Surgery in Southern Dubin, K Rasul, T Allerton, W Cefalu, G Uwaifo, J Paige. Poster Presentation. Annual Conference of the American Society for Metabolic and Bariatric Surgery (ASMBS). June 21, 2012. San Diego, CA.

10. “Eat Less and Exercise More!” Follow-Up at Six Weeks versus Six Months. Dubin, RL,

Kennon AW, Baldwin CB. Poster Presentation Abstract#833-P. The Obesity Society Annual Conference. September 21, 2012. San Antonio, TX.

11. Buckle Up for Patient Safety: Seat Belt Usage in Extremely Obese Patients. Dubin, RL,

Rasul K, Berthaudt LG, Cefalu WT, Uwaifo G. Poster Presentation Abstract# 878-P. The

Obesity Society Annual Conference. September 22, 2012. San Antonio, TX.

12. Effect of Modified Sham Feeding with Orlistat in Overweight and Obese Subjects: A Pilot Study. Dubin, RL, Fusiler, K, Greenway F. Poster Presentation. American Federation for Medical Research. Southern Regional Meeting. February 21, 2013. New Orleans, LA.

13. Safety and Efficacy Using Obesity Medications in the Elderly. Dubin R, Lesnick J, Xanthoudakis E. Poster presentation T-P-3480. The Obesity Society. Obesity Week 2016. 11/04/2016. New Orleans, LA.

14. A Three-Year Assessment of a Popular Commercial Weight Loss Program: A Single

Center Experience. Poster Presentation. Joseph D, Brown H, Wunderlich J, Dodson B,

Dubin R. Poster Presentation T-P-3109. Obesity Week 2017. October 31, 2017.

Washington, DC.

15. Safety and Efficacy Using Anti-Obesity Medications in Elderly Patients. Dubin, R,

Brown, S, McClain, R. Poster Presentation #612 . American Association of Clinical

Endocrinologists. Scientific and Clinical Congress. May 18, 2018. Boston, MA.

16. Medical Therapy in Weight Regain and Suboptimal Weight Loss Following Metabolic

Surgery. Alexander M, Chebli J, Dubin R. American Society of Metabolic and Bariatric

Surgery (ASMBS) 35th Annual Meeting at Obesity Week 2018. November 11-15, 2018. Nashville, TN.

17. Perioperative Safety and Protocol for Managing Insulin Pump Requiring Patients Undergoing

Metabolic and Bariatric Surgery. Chebli J, DeFrancesco J, Dubin, R. American Society of Metabolic

and Bariatric Surgery (ASBMS) 36th Annual Meeting at Obesity Week 2019. November 6, 2019. Eposter #208264. Las Vegas, NV.

18. Skeletal Muscle Loss and Glucagon like Peptide-1 Receptor Agonists.  Poster Presentation. 11th International Symposium on Nutritional Aspects of Musculoskeletal Health. San Diego, California. April 29-May 1, 2024

19. Food Insecurity in African American Women with Obesity: Baseline Physiological Characteristics. John W. Apolzan, PhD, Robbie A. Beyl, PhD, Daniel S. Hsia, MD, Robert L. Dubin, MD, Tiffany Wesley Ardoin, MD, Candice A. Myers, PhD. Poster Presentation. November 4, 2024. The Obesity Society Annual Conference. San Antonio, Texas.

20. Body Composition Changes that occur with GLP-1 based agents: More Questions than Answers. Robert L. Dubin, Steve B. Heymsfield. Poster Presentation. 12th International Symposium on IN Vivo Body Composition Studies. February 22, 2025. Auckland, New Zealand.

• Jazz/Classical Guitar
• Tropical gardening
• Music Recording
• Video Production

• Big Brothers Big Sister of Las Vegas, Big Brother Volunteer, 1992-1996
• Sarasota County Community Specialty Clinics/Internal Medicine/Endocrinology, Staff Volunteer, 2003-present
• Saline Solution, Medical care for the homeless, Volunteer, 2007-2011
• YMCA Venice/South County Center, Wellness/Weight Management Community Liaison, 2009-2011
• IGNITE 2014! Speaker/Guest and presentation for seminar to address health aspects of aging, Valparaiso University, Valparaiso, ID, 2014
• American Medical Association, Diabetes Prevention Program using YMCAs, Presenter and Opinion Leader, 2014-2016
• Community outreach for Metabolic Institute of SW Florida, monthly seminar presentations and 2 television appearances to address the obesity epidemic, 2015-2016
• Community Outreach for Sarasota Memorial Hospital Bariatric Program, monthly seminars and multiple marketing appearances, 2018-2019
• Endocrine For You, Community and Internet outreach services to improve the metabolic health in patients worldwide, 2019-2022
• Guest appearance for ONE-ROGUE online resource for community members of Baton Rouge LA, 11/10/2023
• Science fair judge, Arlington Prep School, Baton Rouge, LA, 05/07/2024
• Facility Tour Guide, Pennington Biomedical Research Center, 2024-present
• Panel Expert, Women’s Health Summit, Pennington Biomedical Research Center, 03/08/2025
• Panel Expert, Men’s Health Summit, Pennington Biomedical Research Center, 08/23/2025
• Presenter, Diabetes Clinical Treatment Update and Overview, Louisiana Primary Care Association (LPCA), 01/29/2026
• Presenter, Clinical Primer for Treating Obesity and Type 2 Diabetes, Louisiana Primary Care Association (LPCA), 01/29/2026
• Expert Panel, Women Health Summit, Pennington Biomedical Research Center, 03/07/2026

• Assistant Clinical Professor of Medicine, Florida State University College of Medicine, Sarasota Campus, 07/2004-2023
• Associate Professor, Louisiana State University Health Sciences, 10/01/2023-present

• Child Name: Benjamin (26 y)
• Child Name: William (23 y)

• Silo-Filler’s Disease treated with Inhaled Nitric Oxide: The Double-Edged Sword of Nox
  Species. Dubin R, Leavy J, Singh N, Kaminsky D.
  Regional Clinical Vignette Winner. ACP-ASIM. Stowe, VT. October 2002.
  National Clinical Vignette Winner. ACP-ASIM. Annual Session. San Diego, CA. April 2003
  2011-2013: Endocrine Fellowship Award for Travel and Resources. LSUHSC. Host: William T Cefalu, MD
  2023: Gold Humanitarian Award: Florida State University College of Medicine, Sarasota Campus.
  2023: Honoree; SRQ TOP DOCTORS (peer review): Endocrinology, Diabetes and Metabolism.
  2023: Florida State University College of Medicine. Guardian of the Mission Community Faculty Award.
  
  Current Research Oversight: (as of 2026)
  1. RAATE and RAATE MCI: Sponsor: BRIGHT-FOCUS A20175472 7/1/17 – current. Exercise Intervention to Reduce Risk of Alzheimer’s Disease in African Americans. This 2-part study is designed to develop and evaluate a physical activity promotion program among elderly African Americans. Primary outcomes for the study will be measures of physical activity, cognitive function, and brain structure and function as assessed by magnetic resonance imaging. PI: Robert Newton, MI: Robert Dubin
  2. ATTAIN-1: Industry Sponsor: Eli Lilly. June 2023-present. A Phase 3 Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once Daily LY3502970 Compared with Placebo in Adult Participants with Obesity or Overweight with Weight-related Complications.
  PI: Robert Dubin
  3. DIAL HEALTH: Sponsor: NIH. NCT05549362. Dec 2022-present. The purpose of this study is to conduct a five-arm pilot and feasibility trial in healthy, young individuals without obesity to evaluate the feasibility and efficacy of dietary intervention approaches to slow mechanisms of aging. PI: Corby Martin, MI: Robert Dubin
  4. Aspirin in Reducing Events in the Elderly-Extension (ASPREE-X) National Institute on Aging/NIH Grant #5U19 AG062687-04. Evaluating the impact that chronic aspirin usage has on multiple outcomes on aging and general health. PI: Robert Dubin
  5. Diabetes Prevention Program Outcomes Study (DPPOS): 2002-present. Sponsor: NIH. 0187-0000 We are part of the DPP-OS consortium. This long-term observational study assesses the effects of either intensive lifestyle interventions versus metformin versus placebo in multiple outcomes. We
  have a cohort of approximately 60 subjects that we continue to follow at our center. PI: Owen Carmichael. MI: Robert Dubin
  6. Asthma Study: Individualized Nutrition to help Asthmatics Improve Lung Function and Energetics. 2022-present. Sponsor: NORC P&F 0846-000. Single center study (N=30) assessing the impact that nutrition, and diet can have multiple outcomes in adults with asthma. (INHALE) PI: Jacob Mey, MI: Robert Dubin
  7. Education and Cognitive Functioning in Later Life: MRI Component. 2023-present. The Nations’ High School Class of 1972. (NLS72) Sponsor: NIH (Primary) 0896-0000. Assessing neuroimaging brain outcomes in older adults. PI: Owen Carmichael. MI: Robert Dubin
  8. REDEFINE2: The 4609 Trial (NN9938-4609) Efficacy and Safety of cagrilinide in combination with semaglutide (CagriSema sc 2.4 mg/2.4 mg) once weekly in participants with overweight or obesity and type2 diabetes. Sponsor: Novo Nordisk PI: Robert Dubin
  9. PROPEL: Promoting Successful Weight Loss in Primary Care in Louisiana using Information Technology. NIH Sponsor. Jan 2023-present PI: Peter Katzmarzak. subMI: Robert Dubin
  10. FACEIT: Fathers and Children Exercising Together (FACEiT) NIH Funding. PI: Robert L. Newton, Jr., PhD, Medical Investigator: Robert Dubin, MD. November 1, 2023
  11. Enobosarm: A Phase 2 Dose-Finding and Proof-of-Concept Study to Evaluate the Effect on Body Composition and Safety of Enobosarm in Patients Treated with Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Chronic Weight Management. Sponsor: Veru Inc. PI: Stephen Heymsfield, MD. MI: Robert Dubin, MD. May 2024.
  12. Bogalusa Heart Study (BHS): BHS BRAIN. Early life glycemic status and Alzheimer’s disease neuroimaging markers in the middle age BHS. Sponsor: NIH. PI: Owen Charmicheal, PhD, MI: Robert Dubin, MD. Oct 2024.
  13. BKR-017: A Phase 1 study of the Safety and Pharmocokinetics of BKR-017 in Individuals on Statin Therapy. Sponsor: Bio Kier Inc. PI: Frank Greenway, MD. MI: Robert Dubin, MD May 2024.
  14. E-Val: Evaluating Glial Acetate metabolism as a Biomarker of Hypoglycemic counterregulation using Spectroscopy. Sponsor: PRCC. PI: David McDougal, PhD. MI: Robert Dubin, MD. April 2024.
  15. GRAMS: GLP-1 Receptor Agonists and the Musculoskeletal System: Sponsor: NIH/LaCats. PI: John Kirwan, PhD. MI: Robert Dubin, MD. May 2025
  16. MPACC: Multicomponent Program for African American Cognition: Rural. Sponsor: PBRC. PI: Robert Newton, PhD. MI: Robert Dubin, MD. Pending
  17. AVANTI: Hypothyroidism: Efficacy and Safety of Armour Thyroid Treatment in Subjects with Primary Hypothyroidism. Sponsor: Abvie, Inc. PI: Frank Greenway. MI: Robert Dubin, MD. Pending
  18. ACCESS: A Phase 2b, Randomized, Double-blind, Placebo-controlled, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of GSBR-1290 in Participants Living with Obesity (Body Mass Index = 30 kg/m2) or Overweight (Body Mass Index = 27 kg/m2) with at Least One Weight-related Comorbidity. Sponsor: Gasherbrum Bio, Inc. PI: Steven Heymfield. MI: Robert Dubin
  19. Boehringer: An active-comparator-controlled, open-label, parallel group study to evaluate the effect of survodutide on energy expenditure and fatty acid oxidation in subjects with obesity. Sponsor: Boehringer Ingelheim. PI: Eric Ravussin. MI: Robert Dubin. May 2025
  20. TRIUMPH-6: A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Retatrutide Treatment in the Maintenance of Weight Reduction in Individuals with Obesity. PI: Steven Heymsfield, MI: Robert Dubin. 2025

• 1992-1996: Big Brothers Big Sister of Las Vegas, Big Brother Volunteer.
  2003-present. Sarasota County Community Specialty Clinics/Internal Medicine/
  Endocrinology. Venice and Sarasota, FL. Staff Volunteer
  2007-2011. Saline Solution. Medical care for the homeless. Sarasota, FL. Volunteer
  2009-2011. YMCA Venice/South County Center. Wellness/Weight Management Community Liaison
  2014: March 12: IGNITE 2014! Speaker/Guest and presentation for seminar to address health aspects of aging. Valparaiso University, Valparaiso, ID. Host: Ausma Mursch.
  2014-2016: American Medical Association. Diabetes Prevention Program using YMCAs. Presenter and Opinion Leader. Presentations performed in Sarasota, Florda and Chicago, IL.
  2015-2016: Community outreach for Metabolic Institute of SW Florida: monthly seminar presentations and 2 television appearances to address the obesity epidemic. Host: Cynthia Koski.
  2018-2019: Community Outreach for Sarasota Memorial Hospital Bariatric Program: monthly seminars and multiple marketing appearances. Host: Dr Jack Rodman.
  Robert L. Dubin, M.D. (page 5) continued
  
  2019-2022: Endocrine For You. Community and Internet outreach services to improve the metabolic health in patients worldwide. Host: Dr Robert Dubin.
  2023: November 10, 2023: guest appearance for ONE-ROGUE online resource for community members of Baton Rouge LA. Host Pepper Roussel.
  2024: May 7. Arlington Prep School: Baton Rouge, LA. Science fair judge.
  2024-present: Pennington Biomedical Research Center. Facility Tour Guide
  2025: March 8. Women’s Health Summit: Pennington Biomedical Research Center: Panel Expert
  2025: August 23. Men’s Health Summit: Pennington Biomedical Research Center. Panel Expert
  2026: January 29. Louisiana Primary Care Association (LPCA). Presenter: Diabetes Clinical Treatment Update and Overview.
  2026: January 29. Presenter. Clinical Primer for Treating Obesity and Type 2 Diabetes. Louisiana Primary Care Association (LPCA).
  2026: March 7. Women Health Summit. Pennington Biomedical Research Center. Expert Panel

Public policy:

*American Medical Association: Preventing Type 2 Diabetes in America. Organizing committee and guest speaker. December 9-10, 2016, Chicago, IL.

*National Council on Aging: in support of the Treat and Reduce Obesity Act (TROA)

I met with multiple members of congress to discuss the importance of TROA passage.

I made 2 separate trips to Washington, DC: March 25-26 and October 28-30, 2025.

*Soy Nutrition International: Consultant and speaker 2025-present

*SNI Global and Foundation for Farming and Agriculture (FFAR) April 6-7, 2026: Intersection of Food Systems and Emerging Obesity Management Medications. Consultant and Committee Member. New Orleans, LA.

Editorial Manuscript Review:

1. American Journal of Medicine: (23-1882) Nov 2023

2. HEALIOS: Endocrine Today: June 2024 (Perspective)

3. Obesity Reviews (OBR-06-23-6281) June 2024

4. Advances in Therapy (ADTH-D-24-00261) June 2024

5. Obesity (Journal) 24-0647-Orig June 2024

6. Advances in Therapy: ADTH-D-24-00417-July 2024

7. HEALIOS: Endocrine today: July 2024 (Perspective)

8. Practice Updates: September 19, 2024 (Editorial)

9. HEALIOS: Endocrine today: September 2024 (Perspective)

10. Diabetes, Obesity and Metabolism: DOM_24-22131-RA Sept 27, 2024

11. Surgery for Obesity and Related Diseases (SOARD) April 2025

12. Obesity: ID 25-0464-OAR. April 2025

13. Obesity: ID c6cdc16e-89af-4fce-830e-2958aeb7010e. May 2025

14. Continued editorial reviews: 2025-2026, Obesity, DOM, ADTH, OB Review

Other Skillsets:

1. Attendant: Endocrine University: American College of Endocrinology. Mayo Clinic, Rochester, March 9-14, 2013

2. Producer: Endocrine for You: Web-based resources for patient care. Created and produced by Robert L. Dubin, MD. RobertDubinMD.com. 2020- present.

3. Reviewer: The Endocrine Society: Application Reviewer for Travel Grants 2024

4. Liaison: The Endocrine Society: Online Member Orientation & Networking Liaison 2024-present

5. Reviewer: American College of Physicians: Abstract Reviewer for Annual ACP Conference 2016-present

6. Expert Witness: Internal Medicine, endocrinology, diabetes, metabolism, and obesity medicine. 2020-present

7. Editorial Board: Obesity (Journal). 2024-2027.

8. Presenter: VUMEDI: Physician educational video resources. Glucagon-like Peptide-1 Receptor Agonist-Based Agents and Weight Loss Composition: Filling the Gaps. October 21, 2024

9. Reviewer: Tulane University: Center of excellence in sex-based biology and medicine. Pilot project grant reviewer. July 1, 2024.

10. Reviewer: Department of Health and Human Services Grant Application. Gertrude Arthur. Launched Pilot and Feasibility Grant. The Role of PNPLA3 Polymorphism in Obesity and Cardiovascular Disease. Dec 2024.

11. Consultant: Soy Nutrition Institute (SNI) Global Meeting Guest Speaker: April 2-4, 2025. Phoenix, AZ.

12. Host: Hansel Visiting Scientist Seminar Series. Pennington Biomedical Research Center. May 1, 2025. Bret Goodpaster, PhD. Effects of Weight Loss on Skeletal Muscle.

13. Moderator of sessions at Society Meetings the Obesity Society. Moderator. Annual Meeting. Atlanta, GA. Nov 3-5, 2025. Organizer / Director